The global diphtheria vaccines market is expected to grow at a significant CAGR during the forecast period (2021-2027). Diphtheria vaccines are vaccination medications that are given to children starting at the age of two to help them develop acquired immunity to DTP (Diphtheria, Tetanus, and Pertussis). The vaccines have been included in the Expanded Programme of Immunization (EPI) vaccination schedule since 1974. The use of DTP as a stand-alone vaccine has decreased significantly. This trend is primarily due to an increase in demand for tetravalent and then pentavalent combination vaccinations. GAVI (Global Alliance for Vaccinations and Immunizations) financing for other DTP-containing vaccines has fueled rising demand for combination products. 

The global Diphtheria vaccine market is expected to be driven by the increased incidence of diphtheria, as well as expanding global governmental support for vaccination programmes. Despite reasons such as rising demand for the DTaP vaccine, rising incidences of diphtheria, tetanus, and pertussis, and increased awareness of the benefits of vaccination, the global diphtheria vaccine market is expected to rise. The industry is projected to be restrained by sporadic cases of vaccinations causing harm and strict regulatory clearance processes. During the forecast period, the global diphtheria vaccine market is predicted to see increased investment in research and development, as well as increased government and institutional support for immunisation programmes and rising demand from emerging nations.

Furthermore, the global drive has been made to put more and more youngsters within the vaccination centers. The World Bank, local governments, and CSR foundations are all working together to promote this cause, which is boosting the market growth. As a result, during the forecast period, the vaccination centres sector is predicted to increase at the fastest rate. The vaccination centers housed a vast stockpile of vaccinations, which aided in the market's growth.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: AJ Vaccines, Bionet-Asia, GlaxoSmithKline plc (GSK), Johnson & Johnson among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Diphtheria Vaccines Market by Segment

By End-User 

• Hospitals

• Clinics

• Vaccination Centers 

Global Diphtheria Vaccines Market by Region